Mr Robert A Mallimson, PHD in Centerbrook, CT - Psychologist

Mr Robert A Mallimson, PHD is a Psychologist based in Centerbrook, Connecticut. Mr Robert A Mallimson is licensed to practice in Connecticut (license number 000685) and his current practice location is 68 Main St, Centerbrook, Connecticut. He can be reached at his office (for appointments etc.) via phone at (860) 767-2266.

NPI number for Mr Robert A Mallimson is 1952492092 and his current mailing address is Po Box 182, 68 Main St, Centerbrook, Connecticut. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1952492092.

Contact Information

	Mr Robert A Mallimson, PHD
	68 Main St, Centerbrook, CT 06409
	(860) 767-2266
	(860) 767-5067

Healthcare Provider's Profile

Full Name	Mr Robert A Mallimson
Gender	Male
Speciality	Psychologist
Location	68 Main St, Centerbrook, Connecticut
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1952492092
Provider Enumeration Date: 09/27/2006
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Mr Robert A Mallimson such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1952492092	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
103T00000X	Psychologist	000685 (Connecticut)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Mr Robert A Mallimson is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Mr Robert A Mallimson, PHD Po Box 182, 68 Main St, Centerbrook, CT 06409 Ph: (860) 767-2266	Mr Robert A Mallimson, PHD 68 Main St, Centerbrook, CT 06409 Ph: (860) 767-2266

News Archive

Data from MiDAS I trial of mild for treatment of LSS to be released

Medical device company Vertos Medical, Inc. has announced the release of additional patient outcomes data from the MiDAS I trial, a prospective, 75-patient study of mild for the treatment of lumbar spinal stenosis. As presented at the Florida Society of Interventional Pain Physicians Annual Meeting in Orlando on May 23, investigators found that study participants reported statistically significant improvement in both their physical and mental well-being six weeks following the mild procedure.

Study examines newly proposed DSM-5 criteria for autism spectrum disorder

Parents should not worry that proposed changes to the medical criteria redefining a diagnosis of autism will leave their children excluded and deemed ineligible for psychiatric and medical care, says a team of researchers led by psychologists at Weill Cornell Medical College.

Protein pathways linked to heart disease, diabetic complications identified in patients with diabetes

Protein pathways that are closely linked to changes in both triglyceride and hemoglobin A1c levels in diabetic patients have been identified in new research by the Intermountain Medical Center Heart Institute in Salt Lake City.

New study sheds light on natural small molecule with antimicrobial effects

Scientists from the Florida campus of The Scripps Research Institute have uncovered the unique mechanism of a powerful natural product with wide-ranging antifungal, antibacterial, anti-malaria and anti-cancer effects.

Mr Robert A Mallimson, PHD - Psychologist in Centerbrook, CT